[
  {
    "ts": null,
    "headline": "Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock?",
    "summary": "GILD jumps 27.2% in six months as FDA nod for twice-yearly HIV drug Yeztugo boosts its HIV franchise and growth outlook.",
    "url": "https://finnhub.io/api/news?id=f8b2c22675443a40b2ae4cbfbb0f902ec696cfb15c05b2f5ba5439289ff5cf0f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751982660,
      "headline": "Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock?",
      "id": 135809832,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "GILD jumps 27.2% in six months as FDA nod for twice-yearly HIV drug Yeztugo boosts its HIV franchise and growth outlook.",
      "url": "https://finnhub.io/api/news?id=f8b2c22675443a40b2ae4cbfbb0f902ec696cfb15c05b2f5ba5439289ff5cf0f"
    }
  },
  {
    "ts": null,
    "headline": "Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?",
    "summary": "Here is how Gilead Sciences (GILD) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=388acf73faa45baa7a361a80eadbd64e64ac7184e5708b0adcf6c949fe28cd93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751982004,
      "headline": "Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?",
      "id": 135808030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Here is how Gilead Sciences (GILD) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=388acf73faa45baa7a361a80eadbd64e64ac7184e5708b0adcf6c949fe28cd93"
    }
  }
]